Chronic interferon exposure drives immunosuppression in tumors
Cancer biology and, in turn, cancer treatment have come a long way in the last few decades. Most…
New stem cell approach targets functional cure for diabetes
New research presented today at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an…
Peacemaker immune cells offer new hope for restoring immune tolerance
‘Peacemaker’ immune cells could help treat diseases ranging from type 1 diabetes to neurodegeneration by restoring immune tolerance, according to a…
Researchers uncover new mechanism linking metabolism, immunity, and skeletal health
Obesity alters bone health not only through increased body weight but also by reshaping the bone marrow environment.…
Donor-derived dendritic cells teach the immune system to accept new livers
UPMC and University of Pittsburgh clinician-scientists have weaned and kept multiple liver transplantation patients off of all immunosuppressant…
Lab-grown food pipe offers hope for children with esophageal conditions
Scientists from Great Ormond Street Hospital (GOSH) and University College London (UCL) have created the first lab‑grown esophagus…
Immune scaffold predicts onset weeks early
A retrievable immune scaffold reveals a 5–7 week presymptomatic window for tracking type 1 diabetes progression, long before…
Scientists capture real-time action of antiviral drugs on herpes
Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works. The…
Engineered extracellular vesicles enable antigen-specific regulatory T cell induction
A research team at the Nano Life Science Institute (WPI-NanoLSI) and the Faculty of Medicine at Kanazawa University…
Regenerative medicine offers a pathway toward curing type 1 diabetes
Type 1 diabetes (T1D) is an autoimmune disorder characterized by the specific destruction of insulin-producing pancreatic β-cells. While…
Novel treatment disrupts tumor immunosuppression in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers, with a five-year survival rate below 10%. University…